Archean Chemical Industries Limited (ACI)
₹478.60 +1.45% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Archean Chemical's revenue was ₹327 Cr (+8.9% year on year, +8.7% on the previous quarter), and net profit ₹30.4 Cr (-24.4% year on year); the operating margin was 20.6%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹327 | +8.9% | +8.7% |
| Operating profit | ₹67.3 | +16.0% | +52.9% |
| Net profit | ₹30.4 | -24.4% | +153.0% |
| EPS (₹) | 2.48 | -23.7% | +127.5% |
| Operating margin | 20.6% | — | — |
ACI delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 29.02% of the ACI shares traded on NSE were taken to delivery, against the stock's own 20-session average of 54.27%. That is lower than usual for this stock. It traded 4.6 times its average daily volume.
Delivery in the last 5 sessions: 49.8% · 65.2% · 60.9% · 65.8% · 29.0%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Archean Chemical Industries Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited. It confirms that share certificates received for dematerialisation during the quarter were duly processed, verified, and cancelled within prescribed timelines. This is a recurring regulatory filing with no operational or financial impact.
- Compliance certificate submitted for the quarter ended September 30, 2026
- Issued by RTA MUFG Intime India Private Limited dated October 3, 2026
- Submitted to exchanges under Regulation 74(5) on October 12, 2026
Archean Chemical Industries (ACI) reported its highest quarterly revenue in five quarters at ₹332.8 Cr for Q1 FY27, a 10.7% YoY increase. A significant milestone was achieved as the bromine derivatives segment (Acume) turned EBITDA positive for the first time. While bromine realizations surged 50% YoY, the company faced logistics headwinds with sea freight costs rising 30-35%. Management confirmed that 60-65% of the massive $249 million (~₹2,066 Cr) semiconductor capex will be deployed within FY27, representing a major structural pivot for the company.
- Consolidated revenue grew 10.7% YoY to ₹332.8 Cr, driven by strong bromine volumes and realizations.
- Bromine realizations increased by 50% YoY, although management noted a recent 30-40% price correction in China.
- Semiconductor capex of $249 million (~₹2,066 Cr) is underway, with 15-20% already incurred and 60-65% planned for FY27.
- Sea freight costs increased by 30% to 35%, impacting landed costs to East and South Asian customers.
- Targeting a bromine production run rate of 20,000 to 25,000 tons by FY28.
Archean Chemical Industries has released the audio recording of its earnings conference call held on August 03, 2026, for the quarter ended June 30, 2026. The company is currently navigating a period of margin compression, with TTM Operating Profit Margin (OPM) at 20.0% compared to 34.8% in FY24. Investors can access the recording to understand management's strategy regarding the Rs 2,066 Cr investment in Silicon Carbide wafers and the status of the 130,000 TPA specialty product pilot plant.
- Earnings conference call conducted on August 03, 2026, at 11:00 AM IST.
- Recording pertains to the financial performance for the quarter ended June 30, 2026.
- Company is managing a TTM revenue base of Rs 1,096 Cr with a market cap of Rs 6,511 Cr.
- Management commentary likely covers the progress of the Rs 2,066 Cr semiconductor-related investment.
Archean Chemical Industries (ACI) reported a consolidated revenue of ₹332.8 Cr for Q1 FY27, an 11% YoY increase driven by strong performance in the Bromine segment. However, consolidated PAT declined 24% YoY to ₹30.4 Cr, impacted by a 12% drop in Industrial Salt revenue and significant logistics headwinds in Gujarat. The Bromine Derivatives business (Acume) turned EBITDA positive at ₹1.9 Cr, while the company progressed its semiconductor foray by signing a Fiscal Support Agreement with the India Semiconductor Mission.
- Bromine segment revenue grew 58% YoY to ₹133.3 Cr with volumes increasing to 4,175 tons
- Industrial Salt volumes fell to 0.98 million tons due to road repair diversions in Gujarat increasing distances by 50-100%
- Acume Chemicals (Bromine Derivatives) turned EBITDA positive at ₹1.9 Cr compared to a ₹2.7 Cr loss in Q1 FY26
- Signed Fiscal Support Agreement with India Semiconductor Mission on May 11, 2026, for its semiconductor fab project
- Investing GBP 15 million (approx. ₹165 Cr) for a 21.84% stake in UK-based Clas-SiC Wafer Fab
Archean Chemical reported a 10.7% YoY increase in consolidated revenue to ₹332.81 Cr for Q1 FY27, but consolidated net profit fell 24.4% to ₹30.35 Cr. The profit decline was primarily driven by a ₹9.98 Cr loss from subsidiaries (Acume, Idealis, etc.) and a doubling of standalone finance costs to ₹8.64 Cr. The company also infused ₹170 Cr into its subsidiary Acume Chemicals to fund its bromine derivative expansion, representing ~8.5% of its net worth.
- Consolidated Revenue rose 10.7% YoY to ₹332.81 Cr from ₹300.59 Cr.
- Consolidated Net Profit dropped 24.4% YoY to ₹30.35 Cr from ₹40.14 Cr.
- Invested ₹170 Cr in subsidiary Acume Chemicals via rights issue on June 17, 2026.
- Standalone finance costs increased 93.8% YoY to ₹8.64 Cr from ₹4.46 Cr.
- Land lease for the entire production facility remains pending renewal since July 2018.
Archean Chemical Industries (ACI) has scheduled its earnings conference call for August 03, 2026, to discuss financial results for the quarter ended June 30, 2026. This comes at a critical time as the company faces margin pressure, with TTM OPM at 20.0% compared to 34.78% in FY24. Investors will be looking for updates on the massive Rs 2,066 Cr Silicon Carbide wafer investment and the status of the 130,000 TPA specialty product pilot plant expected in Q4 FY26. The call will feature the Managing Director and CFO to address operational performance and commodity realization trends.
- Earnings call scheduled for August 03, 2026, at 11:00 AM IST
- Discussion to cover financial performance for the quarter ended June 30, 2026 (Q1 FY27)
- Management participation includes the Managing Director and Chief Financial Officer
- Company is navigating a significant Rs 2,066 Cr investment plan for semiconductor-grade wafers
- Recent quarterly PAT has shown volatility, dropping to Rs 12 Cr in Mar 2026 from Rs 58 Cr in Mar 2025
Archean Chemical Industries Limited (ACI) has responded to queries from the NSE and BSE regarding a significant increase in trading volume observed on July 15-16, 2026. The company clarified that it is in full compliance with SEBI (LODR) Regulations and has disclosed all material events to the exchanges. Management stated there is no undisclosed price-sensitive information or impending corporate actions that would explain the volume spurt. The company attributes the increased trading activity to purely market-driven factors.
- NSE sought clarification on volume movement via email on July 15, 2026
- BSE issued a similar query under Ref. No. L/SURV/ONL/PV/SG/ 2026-2027 / 248 on July 16, 2026
- Company submitted its formal response on July 16, 2026, denying any hidden material developments
- Management confirmed zero undisclosed price-sensitive information or impending corporate actions
Archean Chemical Industries (ACI) has responded to queries from both BSE and NSE regarding a significant increase in the trading volume of its securities. The company clarified that it is in full compliance with SEBI (LODR) Regulations, 2015, and has disclosed all material information to the exchanges. Management stated there is no undisclosed price-sensitive information or impending corporate actions that would explain the volume surge. The movement is attributed purely to market forces.
- Response to BSE e-mail Ref. No. L/SURV/ONL/PV/SG/ 2026-2027 / 248 dated July 16, 2026
- Response to NSE e-mail dated July 15, 2026
- Management confirms no undisclosed price-sensitive information exists as of July 16, 2026
- Company maintains compliance with SEBI (LODR) Regulations, 2015
- Market capitalization stands at Rs 7024 Cr with TTM revenue of Rs 1096 Cr
Archean Chemical Industries (ACI) has announced that its investee company, Offgrid Energy Labs, inaugurated its first 10 MWh Zinc Bromide battery pilot facility in the UK on July 07, 2026. ACI currently holds an 18.14% stake in Offgrid following a USD 12 million investment commitment. This facility marks the transition of proprietary ZincGel technology from lab innovation to commercial pilot-scale production. The development is a strategic forward integration for ACI, as its core bromine business provides the essential raw material for these long-duration energy storage (LDES) systems.
- Inauguration of a 10 MWh demonstration line in Hook, United Kingdom, on July 07, 2026
- ACI holds an 18.14% stake in Offgrid Energy Labs Inc. following the subscription of A1 Preferred Stock
- Total investment commitment of USD 12 million (approx. Rs 100 Cr), representing ~5% of ACI's Net Worth
- Technology targets Long-Duration Energy Storage (LDES) capable of dispatching energy for 10 hours to several days
- No additional financial commitment required from ACI for this specific pilot facility development
Archean Chemical Industries Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by its Registrar & Share Transfer Agent, MUFG Intime India Private Limited, confirms that share certificates received for dematerialization during the quarter ended June 30, 2026, were processed according to guidelines. The registrar verified that the securities were listed on the stock exchanges and physical certificates were mutilated and cancelled. This is a standard administrative filing required for all listed entities in India.
- Compliance confirmed for the quarter ended June 30, 2026
- Certificate issued by Registrar & Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime)
- Confirmation that dematerialized securities are listed on the stock exchanges where earlier securities were listed
- Physical certificates were mutilated and cancelled after due verification by the depository participant
Archean Chemical Industries Limited (ACI) has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, covers the quarter ended June 30, 2026. It confirms that share certificates received for dematerialization were processed, mutilated, and cancelled within prescribed timelines, and the names of depositories were updated in the register of members. This is a standard administrative filing required for all listed entities in India.
- Compliance certificate issued for the quarter ended June 30, 2026
- Registrar MUFG Intime India Private Limited confirmed processing of dematerialization requests within prescribed timelines
- Physical security certificates were mutilated and cancelled after due verification by the depository participant
- The filing was submitted to exchanges on July 6, 2026, following the registrar's confirmation on July 1, 2026
Archean Chemical Industries (ACI) has received a penalty order of Rs 34.24 lakh from the Deputy Commissioner of Income Tax for Assessment Year 2017-18. The penalty is issued under Section 270A for alleged under-reporting and misreporting of income. The company intends to contest the order by filing an appeal before the Commissioner of Income Tax (Appeals). Given the amount is approximately 0.03% of TTM revenue, the company does not expect any material financial impact.
- Penalty of Rs 34,24,248 imposed under Section 270A of the Income Tax Act, 1961
- The order pertains to Assessment Year 2017-18 for alleged under-reported income
- Order was received by the company on June 30, 2026
- Company will file an appeal within the prescribed timelines to contest the demand
Archean Chemical Industries Limited has announced the closure of its trading window starting July 1, 2026, in compliance with SEBI Insider Trading regulations. This closure is ahead of the finalization of the un-audited standalone and consolidated financial results for the quarter ending June 30, 2026. The window will remain closed for all designated persons and their immediate relatives until 48 hours after the results are officially declared. The specific date for the board meeting to approve these results will be communicated in due course.
- Trading window closure effective from July 01, 2026
- Closure pertains to un-audited financial results for the quarter ending June 30, 2026
- Window to reopen 48 hours after the announcement of financial results
- Applies to designated persons and their immediate relatives as per SEBI norms
Archean Chemical Industries Limited (ACI) held its 17th Annual General Meeting on June 12, 2026, where all eight proposed resolutions were passed with the requisite majority. Key approvals included the adoption of audited financial statements for FY 2025-26 and the declaration of a final dividend. Notably, while the re-appointment of Director Ravi Pendurthi was approved with 79.81% overall support, it faced significant opposition from public institutions, with 60% of their votes cast against the resolution.
- Shareholders approved all 8 resolutions, including the adoption of standalone and consolidated financial statements for FY 2025-26.
- The declaration of a final dividend for the financial year ended March 31, 2026, was officially ratified by the members.
- Resolution 3 regarding the re-appointment of Mr. Ravi Pendurthi passed despite 20,110,683 institutional votes (60%) being cast against it.
- Re-appointment of M/s. PKF Sridhar & Santhanam LLP as Statutory Auditors was approved with a 99.84% majority.
- Special resolutions were passed to re-appoint Independent Directors and allow Mr. Kandheri Munuswamy Mohandass to continue beyond age 75.
Archean Chemical Industries Limited (ACI) has received shareholder approval for the re-appointment of two Independent Directors, Mr. K M Mohandass and Mr. C G Sethuram, for a second five-year term effective from December 6, 2026, to December 5, 2031. The company also approved the continuation of Mr. Mohandass's directorship beyond the age of 75. Furthermore, PKF Sridhar & Santhanam LLP has been re-appointed as the statutory auditors for a four-year term ending with the 21st AGM in 2030. Both directors bring extensive experience of approximately 48 years each in finance and the chemical industry.
- Re-appointment of Mr. K M Mohandass and Mr. C G Sethuram as Independent Directors for a 5-year term (2026-2031).
- Approval for Mr. K M Mohandass to continue his directorship after attaining 75 years of age on July 10, 2026.
- PKF Sridhar & Santhanam LLP re-appointed as statutory auditors for a second term of 4 consecutive years until 2030.
- Both re-appointed directors possess significant industry experience of approximately 48 years each.
Financial Performance
Revenue Growth by Segment
Consolidated revenue declined 28% to INR 1,042 Cr in FY25 from INR 1,339 Cr in FY24. For H1 FY26, the revenue mix was 31% Bromine and 68% Industrial Salt. The decline was driven by lower realizations and volumes in both Bromine and Industrial Salt segments.
Geographic Revenue Split
Not explicitly disclosed by region, but the company has a heavy export focus, particularly in liquid bromine where it maintains market leadership.
Profitability Margins
Operating margins moderated to 28.4% in FY25 from 36.2% in FY24 (a 19% decline in margin efficiency). Net Profit Margin was 24.2% in FY24, down 9% from 26.6% in FY23. Margins are expected to settle at 25-26% over the medium term due to gestational losses in new businesses.
EBITDA Margin
Operating Profit Margin was 37.2% in FY24 compared to 45.7% in FY23. The compression is attributed to weak bromine/salt realizations, higher freight costs, and increased power expenses.
Capital Expenditure
Historical capex was INR 200 Cr in FY24. Planned capex includes INR 150-200 Cr annually for FY25-26 for Bromine Phase 2 and Salt expansion. A major Semiconductor project (SPL) is valued at INR 2,066 Cr, funded 50% by the Central Govt, 25% by the Odisha Govt, and 25% by ACIL.
Credit Rating & Borrowing
CRISIL A-/Stable (upgraded from previous levels). Borrowing costs are low as the company was net debt-free post-IPO; however, debt is expected to peak at INR 550-600 Cr by FY28 to fund the semiconductor project.
Operational Drivers
Raw Materials
Brine (natural resource) is the primary raw material, representing the bulk of input requirements. Other costs include power and chemicals used in the steaming-out process.
Import Sources
Sourced locally from leasehold land containing brine reserves, primarily in the Rann of Kutch, Gujarat.
Key Suppliers
Primarily self-sourced through government-leased land; however, the company relies on utility providers for power-intensive operations.
Capacity Expansion
Current industrial salt capacity is being expanded; a specialty product pilot plant with 130,000 tons per annum capacity is expected to be operational by Q4 FY26.
Raw Material Costs
Raw material costs are relatively low due to the cost-effective 'steaming out' process, but profitability is highly sensitive to the realization prices of the final products (Bromine and Salt).
Manufacturing Efficiency
The 'steaming out' process used for bromine extraction is more cost-effective than the 'blowing out' process used in China/Japan, providing a competitive cost advantage.
Logistics & Distribution
Distribution costs are significant due to the export-heavy nature of the business; higher freight costs in FY25 impacted operating profitability.
Strategic Growth
Expected Growth Rate
8-10%
Growth Strategy
Growth will be driven by forward integration into high-margin bromine derivatives (Phase 1 & 2), expansion of industrial salt capacity, and diversification into the semiconductor sector (Silicon Carbide wafers) and energy storage (bromine-based batteries).
Products & Services
Liquid Bromine, Industrial Salt, Sulphate of Potash (SOP), Bromine Derivatives, and Silicon Carbide wafers.
Brand Portfolio
Archean Chemical Industries, Acume Chemicals (ACPL), Ideallis (OHPL).
New Products/Services
Bromine derivatives and Silicon Carbide wafers for the semiconductor industry; the latter is part of a massive INR 2,066 Cr investment.
Market Expansion
Targeting high-potential sectors like semiconductors and energy storage while deepening relationships with existing global clients like Sojitz.
Market Share & Ranking
Leading specialty chemical manufacturer and a top exporter of liquid bromine in India.
Strategic Alliances
Partnership with the Government of India and Government of Odisha for the semiconductor mission project (75% government funding).
External Factors
Industry Trends
The industry is shifting toward specialty derivatives. ACIL is positioning itself by moving from basic bromine to high-value derivatives and entering the semiconductor supply chain to capture higher margins.
Competitive Landscape
Moderate competitive intensity due to high capital requirements and long gestation periods; faces competition from global players in China and Israel.
Competitive Moat
Moat consists of access to limited natural brine resources, high entry barriers (4-5 year gestation for brine fields), and a low-cost production process. These are sustainable due to the scarcity of brine-rich land.
Macro Economic Sensitivity
Highly sensitive to global chemical demand and pricing cycles. GDP growth in end-user industries (agrochemicals, pharma, flame retardants) directly impacts demand.
Consumer Behavior
Increased demand for flame retardants and clear brine fluids in industrial applications is driving bromine consumption.
Geopolitical Risks
Trade barriers or shifts in Chinese/Japanese bromine production (competitors) could impact global supply-demand dynamics.
Regulatory & Governance
Industry Regulations
Operations are subject to environmental norms and lease agreements with state governments for brine extraction. The semiconductor project is governed by the Indian Semiconductor Mission (ISM).
Environmental Compliance
High compliance requirement for brine extraction and chemical processing; non-renewal of leasehold land for brine reserves is a critical regulatory risk.
Taxation Policy Impact
Effective tax rate is standard corporate rate; however, the company is subject to ongoing scrutiny following an Income Tax search in September 2025.
Legal Contingencies
Income Tax Department search conducted in September 2025; as of the latest update, no formal demand or violation notices have been received, making the financial impact unknown.
Risk Analysis
Key Uncertainties
Volatility in product realizations and project execution risks for the large-scale semiconductor plant (INR 2,066 Cr) could impact RoCE, which is expected to drop to 10% in FY26.
Geographic Concentration Risk
High geographic risk as operations are concentrated in a single location vulnerable to weather events like cyclones.
Third Party Dependencies
High dependency on Sojitz for 25% of total revenue and 60-65% of salt sales.
Technology Obsolescence Risk
Risk is mitigated by diversifying into advanced materials like Silicon Carbide wafers and bromine-based energy storage.
Credit & Counterparty Risk
Generally healthy, though high customer concentration (70% from top 10) creates counterparty risk if a major client faces distress.